Medical and Pharmaceutical AstraZeneca shares slide on disappointing lung cancer drug trial results "Dato-DXd" was thought to have immense potential but now appears to be a disappointment Rowan DunneSeptember 10, 2024
Health & Wellness AstraZeneca to expand US manufacturing for cell therapy Investment in AstraZeneca's new Rockville Facility to propel cancer treatment research and development Zartasha MushtaqFebruary 12, 2024
AI and Autonomy AstraZeneca invests US$42M in Verge Genomics AI drug discovery platform Following an initial investment, the deal could potentially be worth up to US$840 million plus royalties Rowan DunneSeptember 11, 2023